ARA-290, a synthetic peptide derived from erythropoietin (EPO), has garnered attention in scientific research due to its potential tissue-protective and anti-inflammatory properties. Unlike EPO, ARA-290 does not appear to impact erythropoiesis, making it a subject of interest in various
